Back

Avoiding false positive SARS-CoV-2 rapid antigen test results with point-of-care molecular testing on residual test buffer

2022-02-24 infectious diseases Title + abstract only
View on medRxiv
Show abstract

ObjectivesAntigen-based rapid diagnostic tests (Ag-RDTs) have been widely used for the detection of SARS-CoV-2 during the Covid-19 pandemic. In settings of low disease prevalence, such as asymptomatic community testing, national guidelines recommend molecular confirmation of positive Ag-RDT results. This often requires patients to be recalled for repeat specimen recollection and subsequent testing in reference laboratories. This project assessed the use of a point-of-care molecular method for SA...

Predicted journal destinations